Targeted molecular imaging of vascular inflammation in cardiovascular disease using nano- and micro-sized agents

Vascular Pharmacology

Volumn 58, Issue 1-2, 2013, Pages 31-38

  McAteer, Martina A ^a   Choudhury, Robin P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adhesion molecules; Atherosclerosis; Endothelial activation; Magnetic resonance imaging; Molecular imaging; Vascular inflammation

Indexed keywords

ATORVASTATIN; CELL ADHESION MOLECULE; CONTRAST MEDIUM; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; IRON OXIDE; LIPOSOME; MICROPARTICLES OF IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ATHEROGENESIS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; CONTRAST SENSITIVITY; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; FLOW CYTOMETRY; HUMAN; IRON STORAGE; LEUKOCYTE; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGE DISPLAY; PHOTOACOUSTICS; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SHEAR STRESS; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; VASCULITIS;

ANIMALS; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CONTRAST MEDIA; ENDOTHELIUM, VASCULAR; FERRIC COMPOUNDS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MICROSPHERES; MOLECULAR IMAGING; NANOPARTICLES; PARTICLE SIZE;

EID: 84871719020     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.10.005     Document Type: Review

References (86)

1. Akhtar A.M., Schneider J.E., Chapman S.J., Jefferson A., Digby J.E., Mankia K., Chen Y., McAteer M.A., Wood K.J., Choudhury R.P. In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging. PLoS One 2010, 5:e12800.
2. Amirbekian V., Lipinski M.J., Briley-Saebo K.C., Amirbekian S., Aguinaldo J.G., Weinreb D.B., Vucic E., Frias J.C., Hyafil F., Mani V., Fisher E.A., Fayad Z.A. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:961-966.
3. Barreiro O., Aguilar R.J., Tejera E., Megias D., de Torres-Alba F., Evangelista A., Sanchez-Madrid F. Specific targeting of human inflamed endothelium and in situ vascular tissue transfection by the use of ultrasound contrast agents. JACC Cardiovasc. Imaging 2009, 2:997-1005.
4. Briley-Saebo K.C., Johansson L.O., Hustvedt S.O., Haldorsen A.G., Bjornerud A., Fayad Z.A., Ahlstrom H.K. Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism. Invest. Radiol. 2006, 41:560-571.
5. Briley-Saebo K.C., Mani V., Hyafil F., Cornily J.C., Fayad Z.A. Fractionated Feridex and positive contrast: in vivo MR imaging of atherosclerosis. Magn. Reson. Med. 2008, 59:721-730.
6. Broisat A., Hernot S., Toczek J., De Vos J., Riou L.M., Martin S., Ahmadi M., Thielens N., Wernery U., Caveliers V., Muyldermans S., Lahoutte T., Fagret D., Ghezzi C., Devoogdt N. Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions. Circ. Res. 2012, 110:927-937.
7. Burtea C., Ballet S., Laurent S., Rousseaux O., Dencausse A., Gonzalez W., Port M., Corot C., Vander Elst L., Muller R.N. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Arterioscler. Thromb. Vasc. Biol. 2012, 32:e36-e48.
8. Chen H.H., Le Visage C., Qiu B., Du X., Ouwerkerk R., Leong K.W., Yang X. MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery. Magn. Reson. Med. 2005, 53:614-620.
9. Chigaev A., Waller A., Zwartz G.J., Buranda T., Sklar L.A. Regulation of cell adhesion by affinity and conformational unbending of alpha4beta1 integrin. J. Immunol. 2007, 178:6828-6839.
10. Choudhury R.P., Fuster V., Fayad Z.A. Molecular, cellular and functional imaging of atherothrombosis. Nat. Rev. Drug Discov. 2004, 3:913-925.
11. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 2001, 107:1255-1262.
12. Dansky H.M., Barlow C.B., Lominska C., Sikes J.L., Kao C., Weinsaft J., Cybulsky M.I., Smith J.D. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1662-1667.
13. Davies M.J., Gordon J.L., Gearing A.J., Pigott R., Woolf N., Katz D., Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol. 1993, 171:223-229.
14. Folco E.J., Sheikine Y., Rocha V.Z., Christen T., Shvartz E., Sukhova G.K., Di Carli M.F., Libby P. Hypoxia but not inflammation augments glucose uptake in human macrophages implications for imaging atherosclerosis with (18)fluorine-labeled 2-deoxy-d-glucose positron emission tomography. J. Am. Coll. Cardiol. 2011, 58:603-614.
15. Frias J.C., Williams K.J., Fisher E.A., Fayad Z.A. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J. Am. Chem. Soc. 2004, 126:16316-16317.
16. Glickson J.D., Lund-Katz S., Zhou R., Choi H., Chen I.W., Li H., Corbin I., Popov A.V., Cao W., Song L., Qi C., Marotta D., Nelson D.S., Chen J., Chance B., Zheng G. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents. Mol. Imaging 2008, 7:101-110.
17. Grieve, S.M., Lønborg, J., Mazhar, J., Tan, T.C., Ho, E., Liu, C.C., Lay, W., Gill, A.J., Kuchel, P., Bhindi, R., Figtree, G.A., in press. Cardiac magnetic resonance imaging of rapid VCAM1 up-regulation in myocardial ischemia-reperfusion injury. Eur. Biophys. J. http://dx.doi.org/10.1007/s00249-012-0857-x.
18. Ha S., Carson A., Agarwal A., Kotov N.A., Kim K. Detection and monitoring of the multiple inflammatory responses by photoacoustic molecular imaging using selectively targeted gold nanorods. Biomed. Opt. Express 2011, 2:645-657.
19. Hamoudeh M., Fessi H. Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles. J. Colloid Interface Sci. 2006, 300:584-590.
20. Hartmann M., Huisman J., Bose D., Jensen L.O., Schoenhagen P., Mintz G.S., Erbel R., von Birgelen C. Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update. Eur. J. Echocardiogr. 2011, 12:313-321.
21. Hemmingsson A., Carlsten J., Ericsson A., Klaveness J., Sperber G.O., Thuomas K.A. Relaxation enhancement of the dog liver and spleen by biodegradable superparamagnetic particles in proton magnetic resonance imaging. Acta Radiol. 1987, 28:703-705.
22. Heyn C., Ronald J.A., Mackenzie L.T., MacDonald I.C., Chambers A.F., Rutt B.K., Foster P.J. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn. Reson. Med. 2006, 55:23-29.
23. Hoyte L.C., Brooks K.J., Nagel S., Akhtar A., Chen R., Mardiguian S., McAteer M.A., Anthony D.C., Choudhury R.P., Buchan A.M., Sibson N.R. Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. J. Cereb. Blood Flow Metab. 2010, 30:1178-1187.
24. Hwang W.Y., Foote J. Immunogenicity of engineered antibodies. Methods 2005, 36:3-10.
25. Kaufmann B.A., Lewis C., Xie A., Mirza-Mohd A., Lindner J.R. Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur. Heart J. 2007, 28:2011-2017.
26. Kaufmann B.A., Sanders J.M., Davis C., Xie A., Aldred P., Sarembock I.J., Lindner J.R. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007, 116:276-284.
27. Kaufmann B.A., Carr C.L., Belcik J.T., Xie A., Yue Q., Chadderdon S., Caplan E.S., Khangura J., Bullens S., Bunting S., Lindner J.R. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler. Thromb. Vasc. Biol. 2010, 30:54-59.
28. Kelly K.A., Allport J.R., Tsourkas A., Shinde-Patil V.R., Josephson L., Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 2005, 96:327-336.
29. Kooi M.E., Cappendijk V.C., Cleutjens K.B., Kessels A.G., Kitslaar P.J., Borgers M., Frederik P.M., Daemen M.J., van Engelshoven J.M. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107:2453-2458.
30. Ley K., Miller Y.I., Hedrick C.C. Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1506-1516.
31. Li H., Cybulsky M.I., Gimbrone M.A., Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am. J. Pathol. 1993, 143:1551-1559.
32. Libby P., Li H. Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J. Clin. Invest. 1993, 92:538-539.
33. Lim Y.L., Lee H.Y., Low S.C., Chan L.P., Goh N.S., Pang S.M. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature. Clin. Exp. Dermatol. 2007, 32:353-358.
34. Lindner J.R., Song J., Christiansen J., Klibanov A.L., Xu F., Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001, 104:2107-2112.
35. Lipinski M.J., Amirbekian V., Frias J.C., Aguinaldo J.G., Mani V., Briley-Saebo K.C., Fuster V., Fallon J.T., Fisher E.A., Fayad Z.A. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn. Reson. Med. 2006, 56:601-610.
36. McAteer M.A., Choudhury R.P. Chapter 4 - applications of nanotechnology in molecular imaging of the brain. Prog. Brain Res. 2009, 180:72-96.
37. McAteer M.A., Sibson N.R., von Zur Muhlen C., Schneider J.E., Lowe A.S., Warrick N., Channon K.M., Anthony D.C., Choudhury R.P. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat. Med. 2007, 13:1253-1258.
38. McAteer M.A., Schneider J.E., Ali Z.A., Warrick N., Bursill C.A., von zur Muhlen C., Greaves D.R., Neubauer S., Channon K.M., Choudhury R.P. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler. Thromb. Vasc. Biol. 2008, 28:77-83.
39. McAteer M.A., Akhtar A.M., von Zur Muhlen C., Choudhury R.P. An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide. Atherosclerosis 2010, 209:18-27.
40. McAteer M.A., von Zur Muhlen C., Anthony D.C., Sibson N.R., Choudhury R.P. Magnetic resonance imaging of brain inflammation using microparticles of iron oxide. Methods Mol. Biol. 2011, 680:103-115.
41. McAteer M.A., Mankia K., Ruparelia N., Jefferson A., Nugent H.B., Stork L.A., Channon K.M., Schneider J.E., Choudhury R.P. A leukocyte-mimetic magnetic resonance imaging contrast agent homes rapidly to activated endothelium and tracks with atherosclerotic lesion macrophage content. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1427-1435.
42. Mendonca Dias M.H., Lauterbur P.C. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn. Reson. Med. 1986, 3:328-330.
43. Michalska M., Machtoub L., Manthey H.D., Bauer E., Herold V., Krohne G., Lykowsky G., Hildenbrand M., Kampf T., Jakob P., Zernecke A., Bauer W.R. Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2350-2357.
44. Morris J.B., Olzinski A.R., Bernard R.E., Aravindhan K., Mirabile R.C., Boyce R., Willette R.N., Jucker B.M. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler. Thromb. Vasc. Biol. 2008, 28:265-271.
45. Nahrendorf M., Jaffer F.A., Kelly K.A., Sosnovik D.E., Aikawa E., Libby P., Weissleder R. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114:1504-1511.
46. Nahrendorf M., Keliher E., Panizzi P., Zhang H., Hembrador S., Figueiredo J.L., Aikawa E., Kelly K., Libby P., Weissleder R. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc. Imaging 2009, 2:1213-1222.
47. Nahrendorf M., McCarthy J.R., Libby P. Over a hump for imaging atherosclerosis: nanobodies visualize vascular cell adhesion molecule-1 in inflamed plaque. Circ. Res. 2012, 110:902-903.
48. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 1998, 18:842-851.
49. Perez-Balderas F., Davis B.G., Van Kasteren S.I., Khrapichev A., Anthony D.C., Sibson N.R. Multimeric iron oxide micro particles: novel high sensitivity and biodegradable MRI contrast agents. Intl. Soc. Mag. Reson. Med. 2010, 18:1899.
50. Perez-Balderas F., Davis B.G., van Kasteren S.I., Khrapichev A., Jefferson A., Bristow C., Serres S., Choudhury R.P., Anthony D.C., Sibson N.R. New biodegradable multimeric MPIO contrast agent shows rapid in vitro and in vivo degradation and high sensitivity contrast. Proc. Intl. Soc. Mag. Reson. Med. 2011, 19:1689.
51. Ramos C.L., Huo Y., Jung U., Ghosh S., Manka D.R., Sarembock I.J., Ley K. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ. Res. 1999, 84:1237-1244.
52. Renshaw P.F., Owen C.S., McLaughlin A.C., Frey T.G., Leigh J.S. Ferromagnetic contrast agents: a new approach. Magn. Reson. Med. 1986, 3:217-225.
53. Rieber J., Meissner O., Babaryka G., Reim S., Oswald M., Koenig A., Schiele T.M., Shapiro M., Theisen K., Reiser M.F., Klauss V., Hoffmann U. Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology. Coron. Artery Dis. 2006, 17:425-430.
54. Rouzet F., Bachelet-Violette L., Alsac J.M., Suzuki M., Meulemans A., Louedec L., Petiet A., Jandrot-Perrus M., Chaubet F., Michel J.B., Le Guludec D., Letourneur D. Radiolabeled fucoidan as a p-selectin targeting agent for in vivo imaging of platelet-rich thrombus and endothelial activation. J. Nucl. Med. 2011, 52:1433-1440.
55. Rudd J.H., Hyafil F., Fayad Z.A. Inflammation imaging in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1009-1016.
56. Ruehm S.G., Corot C., Vogt P., Kolb S., Debatin J.F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001, 103:415-422.
57. Sanz J., Fayad Z.A. Imaging of atherosclerotic cardiovascular disease. Nature 2008, 451:953-957.
58. Schmitz S.A., Coupland S.E., Gust R., Winterhalter S., Wagner S., Kresse M., Semmler W., Wolf K.J. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest. Radiol. 2000, 35:460-471.
59. Serres S., Mardiguian S., Campbell S.J., McAteer M.A., Akhtar A., Krapitchev A., Choudhury R.P., Anthony D.C., Sibson N.R. VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis. FASEB J. 2011, 25:4415-4422.
60. Serres S., Soto M.S., Hamilton A., McAteer M.A., Carbonell W.S., Robson M.D., Ansorge O., Khrapitchev A., Bristow C., Balathasan L., Weissensteiner T., Anthony D.C., Choudhury R.P., Muschel R.J., Sibson N.R. Molecular MRI enables early and sensitive detection of brain metastases. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:6674-6679.
61. Shapiro E.M., Skrtic S., Sharer K., Hill J.M., Dunbar C.E., Koretsky A.P. MRI detection of single particles for cellular imaging. PNAS 2004, 101:10901-10906.
62. Shapiro E.M., Skrtic S., Koretsky A.P. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn. Reson. Med. 2005, 53:329-338.
63. Shapiro E.M., Sharer K., Skrtic S., Koretsky A.P. In vivo detection of single cells by MRI. Magn. Reson. Med. 2006, 55:242-249.
64. Sibson N.R., Blamire A.M., Bernades-Silva M., Laurent S., Boutry S., Muller R.N., Styles P., Anthony D.C. MRI detection of early endothelial activation in brain inflammation. Magn. Reson. Med. 2004, 51:248-252.
65. Sipkins D.A., Cheresh D.A., Kazemi M.R., Nevin L.M., Bednarski M.D., Li K.C. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat. Med. 1998, 4:623-626.
66. Sipkins D.A., Gijbels K., Tropper F.D., Bednarski M., Li K.C., Steinman L. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J. Neuroimmunol. 2000, 104:1-9.
67. Stratta P., Canavese C., Aime S. Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy. Curr. Med. Chem. 2008, 15:1229-1235.
68. Sun D., Nakao S., Xie F., Zandi S., Schering A., Hafezi-Moghadam A. Superior sensitivity of novel molecular imaging probe: simultaneously targeting two types of endothelial injury markers. FASEB J. 2010, 24:1532-1540.
69. Tahara N., Kai H., Ishibashi M., Nakaura H., Kaida H., Baba K., Hayabuchi N., Imaizumi T. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J. Am. Coll. Cardiol. 2006, 48:1825-1831.
70. Trivedi R.A., Mallawarachi C., JM U.K.-I., Graves M.J., Horsley J., Goddard M.J., Brown A., Wang L., Kirkpatrick P.J., Brown J., Gillard J.H. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1601-1606.
71. Tsourkas A., Shinde-Patil V.R., Kelly K.A., Patel P., Wolley A., Allport J.R., Weissleder R. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjug. Chem. 2005, 16:576-581.
72. van Kasteren S.I., Kramer H.B., Gamblin D.P., Davis B.G. Site-selective glycosylation of proteins: creating synthetic glycoproteins. Nat. Protoc. 2007, 2:3185-3194.
73. Villanueva F.S. Molecular imaging of cardiovascular disease using ultrasound. J. Nucl. Cardiol. 2008, 15:576-586.
74. Villanueva F.S., Lu E., Bowry S., Kilic S., Tom E., Wang J., Gretton J., Pacella J.J., Wagner W.R. Myocardial ischemic memory imaging with molecular echocardiography. Circulation 2007, 115:345-352.
75. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 2006, 47:C13-C18.
76. von zur Muhlen C., von Elverfeldt D., Moeller J.A., Choudhury R.P., Paul D., Hagemeyer C.E., Olschewski M., Becker A., Neudorfer I., Bassler N., Schwarz M., Bode C., Peter K. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 2008, 118:258-267.
77. von zur Muhlen C., Peter K., Ali Z.A., Schneider J.E., McAteer M.A., Neubauer S., Channon K.M., Bode C., Choudhury R.P. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. J. Vasc. Res. 2009, 46:6-14.
78. x. Biotechnol. Bioeng. 2005, 92:780-788.
79. Will O., Purkayastha S., Chan C., Athanasiou T., Darzi A.W., Gedroyc W., Tekkis P.P. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 2006, 7:52-60.
80. Winter P.M., Morawski A.M., Caruthers S.D., Fuhrhop R.W., Zhang H., Williams T.A., Allen J.S., Lacy E.K., Robertson J.D., Lanza G.M., Wickline S.A. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha (v) beta3-integrin-targeted nanoparticles. Circulation 2003, 108:2270-2274.
81. Wu Y.L., Ye Q., Foley L.M., Hitchens T.K., Sato K., Williams J.B., Ho C. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1852-1857.
82. Yan Y., Liao Y., Yang L., Wu J., Du J., Xuan W., Ji L., Huang Q., Liu Y., Bin J. Late-phase detection of recent myocardial ischaemia using ultrasound molecular imaging targeted to intercellular adhesion molecule-1. Cardiovasc. Res. 2011, 89:175-183.
83. Yang Y., Yanasak N., Schumacher A., Hu T.C. Temporal and noninvasive monitoring of inflammatory-cell infiltration to myocardial infarction sites using micrometer-sized iron oxide particles. Magn. Reson. Med. 2010, 63:33-40.
84. Ye Q., Wu Y.L., Foley L.M., Hitchens T.K., Eytan D.F., Shirwan H., Ho C. Longitudinal tracking of recipient macrophages in a rat chronic cardiac allograft rejection model with noninvasive magnetic resonance imaging using micrometer-sized paramagnetic iron oxide particles. Circulation 2008, 118:149-156.
85. Yu X., Song S.K., Chen J., Scott M.J., Fuhrhop R.J., Hall C.S., Gaffney P.J., Wickline S.A., Lanza G.M. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn. Reson. Med. 2000, 44:867-872.
86. Zhu D., White R.D., Hardy P.A., Weerapreeyakul N., Sutthanut K., Jay M. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent. J. Nanosci. Nanotechnol. 2006, 6:996-1003.